Biotech Sector: ETF Analysis Shows Overvaluation is Deflating
While the biotech sector had long enjoyed investors’ attention, it was never as pronounced as around the time the pandemic… »
While the biotech sector had long enjoyed investors’ attention, it was never as pronounced as around the time the pandemic… »
Headwinds Are Eroding Credit Buffers On May 17, we announced downward revisions to our global macroeconomic base-case forecasts of between… »
The venerable 105-year-old Boeing Company has been locked in competition with 21-year-old Airbus SE, which was born from the culmination… »
While the biotech sector had long enjoyed investors’ attention, it was never as pronounced as around the time the pandemic… »
Looking at the current and future scenario, we remain cautious in terms of overall risk taking. Some long-standing trends, such… »